Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Benjamin F. Mcgraw III currently holds 15,673 shares of AERIE PHARMACEUTICALS INC (AERI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin F. Mcgraw III has been a net neutral trader of AERI stock. They have purchased $0 and sold $0 worth of shares.
Benjamin F. Mcgraw III's most recent insider trade was on Jun 2, 2026, when they sold 15,673 shares at $0.00 per share.
Benjamin F. Mcgraw III serves as Executive at AERIE PHARMACEUTICALS INC (AERI). They have executed 24 insider transactions totaling $0 over their tenure at the company.
Benjamin F. Mcgraw III holds the position of Executive at AERIE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
Benjamin F. Mcgraw III has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Benjamin F. Mcgraw III was on Nov 21, 2022, when they sold $640.3K worth of AERI shares. This transaction involved 41,984 shares at $15.25 per share.
Benjamin F. Mcgraw III currently owns 15,673 shares of AERIE PHARMACEUTICALS INC (AERI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Benjamin F. Mcgraw III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Benjamin F. Mcgraw III has 24 Form 4 filings on record as an insider at AERIE PHARMACEUTICALS INC.
Set alerts for Benjamin F. Mcgraw III and 40,000+ other insiders.